Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_assertion type Assertion NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_head.
- NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_assertion wasGeneratedBy ECO_0000203 NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_provenance.
- NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_assertion wasDerivedFrom befree-20150227 NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_provenance.
- NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_assertion SIO_000772 24196187 NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_provenance.
- NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_assertion evidence source_evidence_literature NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_provenance.
- NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_assertion description "[MED12 mutations were detected in 54% of classical uterine leiomyomas (15/28) and in 15% of cases in myometrium adjacent to leiomyomas (2/13); 34% of leiomyoma/leiomyomatosis in pelvic/retroperitoneal sites (10/29); 0% of extrauterine leiomyomas (0/29); 8% of smooth muscle tumor of uncertain malignant potential (1/12); 30% of uterine leiomyosarcomas (6/20); and 4% of extrauterine leiomyosarcomas (1/25).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833543.RAs510Pkjxcq5AS6UIcvgpzOLhH3SrR4takW5xeiDfGqQ130_provenance.